OABI Competitors & Alternatives
Compare OmniAb Inc. with similar stocks in the same industry
Biotechnology
OABI
Main Stock$2.43
Tradestie Score
56
Market Cap
$231.77M
Revenue Growth
2.5%
Analyst Upside
+201.8%
Top Competitors
229 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CAPR
Capricor Therapeutics Inc
|
$29.84
|
$357.51M | - | 56 | Compare |
|
LRMR
Larimar Therapeutics, Inc. Common Stock
|
$3.70
|
$355.20M | - | 57 | Compare |
|
CGEM
Cullinan Therapeutics, Inc. Common Stock
|
$18.13
|
$354.45M | - | 60 | Compare |
|
LBRX
LB Pharmaceuticals Inc Common Stock
|
$31.69
|
$353.70M | - | 58 | Compare |
|
PROK
ProKidney Corp. Class A Ordinary Shares
|
$1.72
|
$350.98M | - | 62 | Compare |
|
ALT
Altimmune, Inc. Common Stock
|
$3.02
|
$341.56M | - | 59 | Compare |
|
ANNX
Annexon, Inc. Common Stock
|
$5.59
|
$332.96M | - | 53 | Compare |
|
REPL
Replimune Group, Inc.
|
$11.53
|
$328.62M | - | 63 | Compare |
|
PEPG
PepGen Inc. Common Stock
|
$1.84
|
$323.75M | - | 57 | Compare |
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$9.38
|
$304.12M | - | 61 | Compare |
More OABI Analysis
Data updated: Jun 24, 2026 | Industry: Biotechnology (SIC 8731)
229 stocks in this industry